Physician
Pathology
Dr. Ellen J. Schlette, MD
|
|
Give Review
Ellen Schlette works in the field of Pathology. She went to medical school at University of Texas Medical School. Ellen J. Schlette, MD is also published. She has 45 publications published. The lastest publication: "Correlation between FDG/PET findings, histological features, clinical characteristics and survival in 332 patients with chronic lymphocytic leukemia.' Ellen J. Schlette accepts Medicare payments and is listed with Medicare.gov.
Publications
- Correlation between FDG/PET findings, histological features, clinical characteristics and survival in 332 patients with chronic lymphocytic Leukemia.
- c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin Lymphoma.
- Rapid Response to Vemurafenib in a Heavily Pretreated Patient With Hairy Cell Leukemia and a BRAF Mutation.
- Late extramedullary recurrence of adult onset Burkitt's Lymphoma mimicking peritoneal carcinomatosis.
- Chronic Lymphocytic Leukemia With Central Nervous System Involvement: A High-Risk Disease?
- Expression and effects of inhibition of IGF-IR tyrosine kinase in mantle cell Lymphoma.
- Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin Lymphomas.
- Immunohistochemical detection of ZAP70 in chronic lymphocytic Leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression.
- Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic Leukemia.
- Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic Leukemia.
- Bone marrow involvement by marginal zone B-cell Lymphomas of different types.
- Fine-needle aspiration biopsy findings in patients with small lymphocytic Lymphoma transformed to hodgkin Lymphoma.
- c-Jun expression and activation are restricted to CD30+ lymphoproliferative Disorders.
- Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin Lymphomas.
- Survivin expression predicts poorer prognosis in anaplastic large-cell Lymphoma.
- Mantle cell Lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.
- Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver Disease: role of alkaline phosphatase.
- The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell Lymphoma with wild-type or mutated p53.
- ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell Lymphoma.
- Pleural posttransplantation lymphoproliferative disorder following liver transplantation.
- Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell Lymphoma associated with t(1...
- Leukemic mantle cell Lymphoma: clinical and pathologic spectrum of twenty-three cases.
- TCL1 shows a regulated expression pattern in chronic lymphocytic Leukemia that correlates with molecular subtypes and proliferative state.
- Cytogenetic findings in mantle cell Lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities.
- Mature B-cell Leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
- CD23 expression in mantle cell Lymphoma: clinicopathologic features of 18 cases.
- CD79b expression in chronic lymphocytic Leukemia. Association with trisomy 12 and atypical immunophenotype.
- Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up.
- Mature B-cell Leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
- Leukemic mantle cell Lymphoma with cells resembling prolymphocytes.
- Expression of bcl-3 in chronic lymphocytic Leukemia correlates with trisomy 12 and abnormalities of chromosome 19.
- Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin Lymphomas.
- Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt Lymphoma.
- Outcomes in patients with splenic marginal zone Lymphoma and marginal zone Lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
- The t(14;19)(q32;q13)-positive small B-Cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
- Nelarabine activity in Acute biphenotypic leukemia.
- The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell Lymphomas.
- MYC translocation in Chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.
- Immunophenotypic study of basophils by multiparameter flow cytometry.
- Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic Leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR...
- Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML).
- Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia.
- mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated Acute myeloid leukemia cells.
- p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic Leukemia receiving frontline chemo-immunotherapy.
Schools
U Of Tx Med Sch At Houston
Conditions Treated
- Acute Leukemia
- Anemia
- Aortic Embolism and Thrombosis
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
University of Texas Health Science Center -
University of Texas Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932298924 |
| Last Name Of The Provider | SCHLETTE |
| First Name Of The Provider | ELLEN |
| View All |
Similar Doctors
|
|
Dr. Cristina Montalvo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mike Perez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Jonasch, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mary E. Kling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yve T. Huttenbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle L. Eskue, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet M. Bruner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel M. Santala, MD |
|
|
Dr. Ying Ye, MD |
|
|
Dr. Malekh M. Alshaikhmohamed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rabia Shafi, MD |
|
|
Dr. Liping Song, MD |
|
|
Elnora Y. Baker |
|
|
Michael W. Thompson |